Search results

Experienced prescriber Dr Laurence Kemp will explore the “complex” role of medicinal cannabis in treating chronic […] The post Webinar to explore role of medicinal cannabis in treating chronic pain appeared first on Cannabiz. Continue reading...

Queensland start-up, The People’s Plant, has described progress over recent months as “incredibly satisfying” as it […] The post Start-up cultivator making ‘incredibly satisfying’ progress appeared first on Cannabiz. Continue reading...

Army veteran and medicinal cannabis advocate and campaigner Derek Pyrah has been arrested in New South […] The post Army veteran and medicinal cannabis advocate arrested after roadside test appeared first on Cannabiz. Continue reading...

The Chinese part-owner of Tasmanian Botanics has taken all-but full control of the company after completing […] The post Chinese firm Yongji Health completes $31m takeover of Tasmanian Botanics appeared first on Cannabiz. Continue reading...

Cannabis Warehouse has been thrown into disarray with the company operating at “limited capacity”, its co-founders […] The post ‘Unpaid debt’ and ‘radio silence’: questions mount for Cannabis Warehouse amid co-founder dispute appeared first on Cannabiz. Continue reading...

Curaleaf has accused MedReleaf Australia parent Aurora Cannabis of misleading shareholders by rejecting its hostile takeover […] The post Curaleaf questions Aurora share sales as hostile takeover fight escalates appeared first on Cannabiz. Continue reading...

Neurotech International chief executive and managing director Dr Anthony Filippis has resigned after 19 months in […] The post News in brief: Filippis exits Neurotech; Elixinol completes US sale appeared first on Cannabiz. Continue reading...

BLS Pharmaceuticals has flagged potential upside to its FY27 revenue guidance, revealing its forecast of $105 […] The post BLS sees potential FY27 ‘upside’ as UK facility nears launch appeared first on Cannabiz. Continue reading...

Cannabis may help alleviate symptoms of some eating disorders, including anorexia, with a large international survey […] The post Cannabis may ease anorexia symptoms, Australian study finds appeared first on Cannabiz. Continue reading...

Less than a fortnight after Vitura’s CEO identified Doctors on Demand as “pivotal” to its profitability […] The post Vitura faces $6m revenue hit as Bupa redirects Doctors on Demand patients appeared first on Cannabiz. Continue reading...

Improvements in chronic pain and anxiety in medicinal cannabis patients were maintained for up to 12 […] The post Project Twenty21 Australia finds year-long improvements in pain and anxiety appeared first on Cannabiz. Continue reading...

Importers and domestic producers are continuing to vastly overestimate how much cannabis they need as the […] The post Déjà vu for ODC as inflated forecasts risk tying up national cannabis quota appeared first on Cannabiz. Continue reading...

MedReleaf Australia parent Aurora Cannabis has urged shareholders to reject the hostile takeover bid by Curaleaf, […] The post ‘Inadequate and opportunistic’: Aurora formally rejects takeover bid appeared first on Cannabiz. Continue reading...

Medicinal Cannabis Council Australia is assessing the prospects of a new national compassionate access scheme following […] The post MCCA ‘re-evaluating’ subsidised medicinal cannabis scheme appeared first on Cannabiz. Continue reading...

Hemp Foods Australia parent Elixinol Wellness has hailed a “transformational” H1 FY26 after slashing its losses […] The post Elixinol cuts H1 loss as it announces deal to sell US hemp business appeared first on Cannabiz. Continue reading...

Pastilles have overtaken flower to become the most prescribed dosage form for women through the Special […] The post Pastilles overtake flower as most prescribed dosage form for women appeared first on Cannabiz. Continue reading...

Another committee is being established to examine the regulatory landscape of medicinal cannabis as the industry […] The post Members sought for new group to ‘identify and respond’ to regulatory issues appeared first on Cannabiz. Continue reading...

Clinical biotech Argent BioPharma cut its annual loss by 57% to $7.7 million in FY26 as […] The post Argent BioPharma halves losses but faces funding ‘uncertainty’ appeared first on Cannabiz. Continue reading...

Epsilon Healthcare cut losses by 65% in the first six months of its financial year, driven […] The post Epsilon narrows losses by 65% appeared first on Cannabiz. Continue reading...

Cann Group has reported a normalised loss after tax of $14.7 million, a 20% improvement on […] The post Cann Group entering FY27 with ‘real momentum’, chairman says after year of financial juggling appeared first on Cannabiz. Continue reading...